JF
VRDN icon

Jump Financial’s Viridian Therapeutics VRDN Stock Holding History

Jump Financial’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
+64,111
New +$1.9M 0.02% 836
2024
Q4 		– Sell
-141,978
Closed -$3.23M – 2051
2024
Q3 		$3.23M Buy
141,978
+123,178
+655% +$2.01M 0.07% 345
2024
Q2 		$245K Buy
+18,800
New +$260K ﹤0.01% 1469
2023
Q4 		– Sell
-61,654
Closed -$946K – 2294
2023
Q3 		$946K Buy
61,654
+12,623
+26% +$241K 0.04% 696
2023
Q2 		$1.17M Sell
49,031
-2,716
-5% -$69.7K 0.04% 603
2023
Q1 		$1.32M Buy
51,747
+21,962
+74% +$704K 0.05% 502
2022
Q4 		$870K Sell
29,785
-7,230
-20% -$167K 0.05% 539
2022
Q3 		$760K Buy
37,015
+10,387
+39% +$187K 0.03% 727
2022
Q2 		$308K Buy
+26,628
New +$358K 0.01% 1055

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return